Skip to main content
Anteris Technologies Global Corp. logo

Anteris Technologies Global Corp. — Investor Relations & Filings

Ticker · AVR ISIN · US03675P1021 ASX Manufacturing
Open in API
Filings indexed 1,664 across all filing types
Latest filing 2022-01-23 Interim / Quarterly Rep…
Country US United States of America
Listing ASX AVR

About Anteris Technologies Global Corp.

https://anteristech.com/

Anteris Technologies is a structural heart company focused on the development and commercialization of medical devices for heart valve disease. Its lead product is the DurAVR® Transcatheter Heart Valve (THV), a biomimetic valve designed for patients with severe aortic stenosis. The DurAVR® THV is engineered to mimic the performance of a healthy human aortic valve, aiming to restore normal, laminar blood flow. Clinical studies have shown the device delivers a favorable hemodynamic profile, characterized by low pressure gradients and a significant reduction in prosthesis-patient mismatch (PPM), even in patients with challenging anatomies. The company is advancing its technology through pivotal clinical trials to establish a new standard in transcatheter aortic valve replacement (TAVR) and improve long-term patient outcomes.

Recent filings

Filing Released Lang Actions
Successful Interim Results for the First-In-Human Trial 3 pages 224.4KB
Interim / Quarterly Report Classification · 90% confidence The document is an ASX announcement dated 24 January 2022 reporting on the successful interim results of a first-in-human trial for the DurAVR device by Anteris Technologies Ltd. It provides detailed clinical trial results and commentary from medical professionals and company executives. The content focuses on interim study objectives and patient outcomes rather than full financial statements or comprehensive financial performance. The document length is 6961 characters, which is sufficient to contain substantive information. The nature of the content is a clinical trial interim results update, which aligns with an Interim / Quarterly Report (IR) category as it reports substantive data for a period shorter than a full fiscal year. It is not an earnings release or annual report, nor is it a regulatory filing or announcement of a report. Therefore, the best classification is Interim / Quarterly Report (IR). Q1 2022
2022-01-23 English
Notification of cessation of securities - AVR 5 pages 25.7KB
Regulatory Filings Classification · 95% confidence The document is titled 'Notification of cessation of +securities' and details the lapse or expiration of certain securities (options) for Anteris Technologies Ltd. It provides specific information about the securities that have ceased, the reasons for cessation, and the updated issued capital following these changes. There are no financial statements, management discussion, or earnings data present. The document is an official announcement regarding changes in the company's securities, specifically the cessation of certain options. This fits the category of Regulatory Filings (RNS) as it is a regulatory announcement about securities status changes that does not fit into more specific categories like capital changes or director dealings. The document length is under 5,000 characters, and it is a direct announcement rather than a report or presentation.
2022-01-11 English
Cleansing Notice 2 pages 167.5KB
Share Issue/Capital Change Classification · 95% confidence The document is an ASX announcement dated 11 January 2022 regarding the issuance of 750 new fully paid ordinary shares following the conversion of unlisted options. It references compliance with the Corporations Act 2001 and provides a cleansing notice under section 708A(5)(e). The content focuses on the details of the share issuance and legal compliance related to the capital raising event. The document is short (2942 characters) and is an announcement of a share issue rather than a full financial report or detailed capital structure update. Given the nature of the announcement about new shares issued and the legal cleansing notice, the most appropriate classification is Share Issue/Capital Change (SHA).
2022-01-10 English
Application for quotation of securities - AVR 8 pages 29.9KB
Share Issue/Capital Change Classification · 95% confidence The document is an application for quotation of securities on the ASX, detailing the issuance and conversion of options into ordinary shares. It includes specifics about the securities to be quoted, issue dates, and the total number of securities on issue. This type of document is related to changes in the company's capital structure, specifically the issuance and quotation of new shares resulting from option exercises. It is not a financial report, earnings release, or management discussion. It fits the category of announcements regarding share issues or capital changes.
2022-01-09 English
New Patent Application for ADAPT 2 pages 163.9KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 5 January 2022 from Anteris Technologies Ltd. It discusses the filing of a provisional patent application related to their ADAPT technology, describing the new patent's potential impact on manufacturing and commercialization. There is no financial data, no mention of financial results, no regulatory filings, no meeting materials, no voting results, no management changes, no legal proceedings, no capital changes, and no other report types. The document is a company announcement about intellectual property and patent application, which does not fit into any of the specific financial or regulatory report categories. Therefore, the best fitting category is Regulatory Filings (RNS), which is the fallback for miscellaneous announcements that do not fit other categories. The document length is under 5,000 characters and is a standalone announcement, not a report publication notice or certification.
2022-01-04 English
Exercise of Underwritten Listed Options 1 page 167.
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 29 December 2021 regarding the exercise of listed options by Anteris Technologies Ltd. It details the gross proceeds from the exercise of options, the number of options exercised by existing holders, and the underwriting of the shortfall by Evolution Capital Pty Ltd. The content focuses on a capital raising event through option exercises, which is a financing activity. The document is relatively short (2300 characters) and is a direct announcement of a financing event, not a full financial report or detailed presentation. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2021-12-28 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.